Xencor (XNCR) Net Margin (2013 - 2026)

Xencor (XNCR) posted quarterly Net Margin of 2855.09% for Q1 2026, down 270642.0% year-over-year from N/an in Q1 2025, and down 12017.73% quarter-over-quarter from 23.56% in Q4 2025.

Xencor (XNCR) Net Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Net Margin for 14 consecutive years, with 2855.09% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Margin fell 270642.0% year-over-year to 2855.09%; the TTM figure through Mar 2026 stood at 177.12% (down 1120.0% YoY), while the FY2025 annual figure was 73.37%, up 14071.0% from the prior year.
  • Net Margin eased to 2855.09% in Q1 2026 per XNCR's latest filing, from 23.56% in the prior quarter.
  • Across five years, Net Margin topped out at 27.6% in Q1 2022 and bottomed at 2855.09% in Q1 2026.
  • Historically, Net Margin has averaged 297.03% across 5 years, with a median of 112.5% in 2022.
  • Annual changes were most pronounced in 2025 — Net Margin surged 31463 bps — and 2026, when it sank 270642 bps.
  • Xencor's Net Margin stood at 55.72% in 2022, then grew by 7 bps to 51.57% in 2023, then slumped by 70 bps to 87.51% in 2024, then soared by 73 bps to 23.56% in 2025, then sank by 12018 bps to 2855.09% in 2026.
  • Business Quant data shows XNCR's Net Margin at 2855.09% in Q1 2026, 23.56% in Q4 2025, and 28.7% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Xencor 1.73 Bn 1.36 Bn - -42.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.40%
Mar 31, 2026 -2,855.09%
Dec 31, 2025 -23.56%
Sep 30, 2025 -28.70%
Jun 30, 2025 -70.69%
Mar 31, 2025 -148.68%
Dec 31, 2024 -87.51%
Sep 30, 2024 -266.59%
Jun 30, 2024 -287.71%
Mar 31, 2024 -463.31%
Dec 31, 2023 -51.57%
Sep 30, 2023 -40.99%
Jun 30, 2023 -156.28%
Mar 31, 2023 -308.26%
Dec 31, 2022 -55.72%
Sep 30, 2022 -120.00%
Jun 30, 2022 -112.50%
Mar 31, 2022 27.60%
Dec 31, 2021 47.44%
Sep 30, 2021 -204.19%